메뉴 건너뛰기




Volumn 4, Issue 13, 2012, Pages 1565-1575

Detection of erythropoiesis-stimulating agents in human anti-doping control: Past, present and future

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PEGINESATIDE; RECOMBINANT ERYTHROPOIETIN; REPOTIN; SHANPOIETIN; UNCLASSIFIED DRUG;

EID: 84864447922     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.153     Document Type: Review
Times cited : (21)

References (78)
  • 2
    • 0023907075 scopus 로고
    • Development of techniques for the detection of blood doping in sport
    • Berglund B. Development of techniques for the detection of blood doping in sport. Sports Med. 5(2), 127-135 (1988).
    • (1988) Sports Med. , vol.5 , Issue.2 , pp. 127-135
    • Berglund, B.1
  • 3
    • 0020319934 scopus 로고
    • Blood doping and related issues: A brief review
    • Gledhill N. Blood doping and related issues: A brief review. Med. Sci. Sports Exerc. 14(3), 183-189 (1982).
    • (1982) Med. Sci. Sports Exerc. , vol.14 , Issue.3 , pp. 183-189
    • Gledhill, N.1
  • 4
    • 0023120533 scopus 로고
    • Correction of the anemia of end-stage renal disease with recombinant human erythropoietin Results of a combined Phase I and II clinical trial
    • Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined Phase I and II clinical trial. N. Engl. J. Med. 316(2), 73-78 (1987).
    • (1987) N. Engl. J. Med. , vol.316 , Issue.2 , pp. 73-78
    • Eschbach, J.W.1    Egrie, J.C.2    Downing, M.R.3    Browne, J.K.4    Adamson, J.W.5
  • 5
    • 0033624047 scopus 로고    scopus 로고
    • A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes
    • Parisotto R, Gore CJ, Emslie KR et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85(6), 564-572 (2000).
    • (2000) Haematologica , vol.85 , Issue.6 , pp. 564-572
    • Parisotto, R.1    Gore, C.J.2    Emslie, K.R.3
  • 6
    • 0342646961 scopus 로고    scopus 로고
    • Recombinant erythropoietin in urine
    • Lasne F, De Ceaurriz J. Recombinant erythropoietin in urine. Nature 405(6787), 635 (2000).
    • (2000) Nature , vol.405 , Issue.6787 , pp. 635
    • Lasne, F.1    De Ceaurriz, J.2
  • 8
    • 0035895071 scopus 로고    scopus 로고
    • Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin
    • Skibeli V, Nissen-Lie G, Torjesen P. Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98(13), 3626-3634 (2001).
    • (2001) Blood , vol.98 , Issue.13 , pp. 3626-3634
    • Skibeli, V.1    Nissen-Lie, G.2    Torjesen, P.3
  • 9
    • 0035716187 scopus 로고    scopus 로고
    • Structural analysis of sulfated N-linked oligosaccharides in erythropoietin
    • Kawasaki N, Haishima Y, Ohta M et al. Structural analysis of sulfated N-linked oligosaccharides in erythropoietin. Glycobiology 11(12), 1043-1049 (2001).
    • (2001) Glycobiology , vol.11 , Issue.12 , pp. 1043-1049
    • Kawasaki, N.1    Haishima, Y.2    Ohta, M.3
  • 10
    • 84864490702 scopus 로고    scopus 로고
    • Erythropoietin - Influence of physical strain and application on concentration in blood and urine
    • 4). Schänzer W (Ed. Sport und Buch Strauss, Cologne, Germany, 319-321
    • Breidbach A, Platen P, Schänzer W. Erythropoietin - influence of physical strain and application on concentration in blood and urine. In: RECENT Advances in Doping Analysis (4). Schänzer W (Ed.). Sport und Buch Strauss, Cologne, Germany, 319-321 (1997).
    • (1997) Recent Advances in Doping Analysis
    • Breidbach, A.1    Platen, P.2    Schänzer, W.3
  • 11
    • 0037114935 scopus 로고    scopus 로고
    • Detection of isoelectric profiles of erythropoietin in urine: Differentiation of natural and administered recombinant hormones
    • Lasne F, Martin L, Crepin N, De Ceaurriz J. Detection of isoelectric profiles of erythropoietin in urine: Differentiation of natural and administered recombinant hormones. Anal. Biochem. 311(2), 119-126 (2002).
    • (2002) Anal. Biochem. , vol.311 , Issue.2 , pp. 119-126
    • Lasne, F.1    Martin, L.2    Crepin, N.3    De Ceaurriz, J.4
  • 12
    • 0035400290 scopus 로고    scopus 로고
    • Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures
    • Lasne F. Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J. Immunol. Methods 253(1-2), 125-131 (2001).
    • (2001) J. Immunol. Methods , vol.253 , Issue.1-2 , pp. 125-131
    • Lasne, F.1
  • 13
    • 67649222109 scopus 로고    scopus 로고
    • Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures
    • Lasne F. Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. Methods Mol. Biol. 536, 213-219 (2009).
    • (2009) Methods Mol. Biol. , vol.536 , pp. 213-219
    • Lasne, F.1
  • 14
    • 47749093921 scopus 로고    scopus 로고
    • Identification of zinc-alpha-2- glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS
    • Reichel C. Identification of zinc-alpha-2- glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS. J. Mass Spectrom. 43(7), 916-923 (2008).
    • (2008) J. Mass Spectrom. , vol.43 , Issue.7 , pp. 916-923
    • Reichel, C.1
  • 15
    • 34250809530 scopus 로고    scopus 로고
    • Isoelectric profiles of human erythropoietin are different in serum and urine
    • Lasne F, Martin L, Martin JA, De Ceaurriz J. Isoelectric profiles of human erythropoietin are different in serum and urine. Int. J. Biol. Macromol. 41(3), 354-357 (2007).
    • (2007) Int. J. Biol. Macromol. , vol.41 , Issue.3 , pp. 354-357
    • Lasne, F.1    Martin, L.2    Martin, J.A.3    De Ceaurriz, J.4
  • 16
    • 0014949207 scopus 로고
    • Cleavage of structural proteins during the assembly of the head of bacteriophage T4
    • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259), 680-685 (1970).
    • (1970) Nature , vol.227 , Issue.5259 , pp. 680-685
    • Laemmli, U.K.1
  • 17
    • 0030945210 scopus 로고    scopus 로고
    • A probable conformational difference between recombinant and urinary erythropoietins
    • Kung CK, Goldwasser E. A probable conformational difference between recombinant and urinary erythropoietins. Proteins 28(1), 94-98 (1997).
    • (1997) Proteins , vol.28 , Issue.1 , pp. 94-98
    • Kung, C.K.1    Goldwasser, E.2
  • 18
    • 77953674493 scopus 로고    scopus 로고
    • Towards the screening of urinary EPO by SDS-PAGE analysis
    • 15). Schänzer et al. (Eds Sportverlag Strauss, Cologne, Germany
    • Desharnais P, Ayotte C. Towards the screening of urinary EPO by SDS-PAGE analysis. In: RECENT Advances in Doping Analysis (15). Schänzer et al. (Eds). Sportverlag Strauss, Cologne, Germany (2007).
    • (2007) Recent Advances in Doping Analysis
    • Desharnais, P.1    Ayotte, C.2
  • 19
    • 77449130942 scopus 로고    scopus 로고
    • Erythropoietin and analogs
    • Reichel C, Gmeiner G. Erythropoietin and analogs. Handb. Exp. Pharmacol. 2010(195), 251-294 (2010).
    • (2010) Handb. Exp. Pharmacol. , vol.2010 , Issue.195 , pp. 251-294
    • Reichel, C.1    Gmeiner, G.2
  • 20
    • 38749137803 scopus 로고    scopus 로고
    • Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels
    • Kohler M, Ayotte C, Desharnais P et al. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Int. J. Sports Med. 29(1), 1-6 (2008).
    • (2008) Int. J. Sports Med. , vol.29 , Issue.1 , pp. 1-6
    • Kohler, M.1    Ayotte, C.2    Desharnais, P.3
  • 21
    • 65749093331 scopus 로고    scopus 로고
    • SDS-PAGE of recombinant and endogenous erythropoietins: Benefits and limitations of the method for application in doping control
    • Reichel C, Kulovics R, Jordan V, Watzinger M, Geisendorfer T. SDS-PAGE of recombinant and endogenous erythropoietins: Benefits and limitations of the method for application in doping control. Drug Test. Anal. 1(1), 43-50 (2009).
    • (2009) Drug Test. Anal. , vol.1 , Issue.1 , pp. 43-50
    • Reichel, C.1    Kulovics, R.2    Jordan, V.3    Watzinger, M.4    Geisendorfer, T.5
  • 22
    • 77950567285 scopus 로고    scopus 로고
    • Sarcosyl-Page: A new method for the detection of Mircera®- and EPO-doping in blood
    • Reichel C, Abzieher F, Geisendorfer T. SARCOSYL-PAGE: A new method for the detection of Mircera®- and EPO-doping in blood. Drug Test. Anal. 1(11-12), 494-504 (2009).
    • (2009) Drug Test. Anal. , vol.1 , Issue.11-12 , pp. 494-504
    • Reichel, C.1    Abzieher, F.2    Geisendorfer, T.3
  • 23
    • 84855245023 scopus 로고    scopus 로고
    • The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design
    • Reichel C. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design. Drug Test. Anal. 3(11-12), 883-891 (2011).
    • (2011) Drug Test. Anal. , vol.3 , Issue.11-12 , pp. 883-891
    • Reichel, C.1
  • 25
    • 54249163993 scopus 로고    scopus 로고
    • Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo®
    • Llop E, Gutiérrez-Gallego R, Segura J, Mallorquí J, Pascual JA. Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo®). Anal. Biochem. 383(2), 243-254 (2008).
    • (2008) Anal. Biochem. , vol.383 , Issue.2 , pp. 243-254
    • Llop, E.1    Gutiérrez-Gallego, R.2    Segura, J.3    Mallorquí, J.4    Pascual, J.A.5
  • 26
    • 77953858371 scopus 로고    scopus 로고
    • IEF pattern classification-derived criteria for the identification of epoetin-delta in urine
    • Lamon S, Boccard J, Sottas PE et al. IEF pattern classification-derived criteria for the identification of epoetin-delta in urine. Electrophoresis 31(12), 1918-1924 (2010).
    • (2010) Electrophoresis , vol.31 , Issue.12 , pp. 1918-1924
    • Lamon, S.1    Boccard, J.2    Sottas, P.E.3
  • 27
    • 0034997401 scopus 로고    scopus 로고
    • Development and characterization of novel erythropoiesis stimulating protein (NESP)
    • Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br. J. Cancer 84(Suppl. 1), 3-10 (2001).
    • (2001) Br. J. Cancer , vol.84 , Issue.SUPPL.1 , pp. 3-10
    • Egrie, J.C.1    Browne, J.K.2
  • 28
    • 0036840574 scopus 로고    scopus 로고
    • Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin and endogenous erythropoietin from human urine
    • Catlin DH, Breidbach A, Elliott S, Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin and endogenous erythropoietin from human urine. Clin. Chem. 48(11), 2057-2059 (2002).
    • (2002) Clin. Chem. , vol.48 , Issue.11 , pp. 2057-2059
    • Catlin, D.H.1    Breidbach, A.2    Elliott, S.3    Glaspy, J.4
  • 29
    • 33750973533 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease
    • Macdougall IC, Robson R, Opatrna S et al. Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 1(6), 1211-1215 (2006).
    • (2006) Clin. J. Am. Soc. Nephrol. , vol.1 , Issue.6 , pp. 1211-1215
    • Macdougall, I.C.1    Robson, R.2    Opatrna, S.3
  • 30
    • 66749138979 scopus 로고    scopus 로고
    • Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control
    • Lasne F, Martin L, Martin JA, De Ceaurriz J. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control. Haematologica 94(6), 888-890 (2009).
    • (2009) Haematologica , vol.94 , Issue.6 , pp. 888-890
    • Lasne, F.1    Martin, L.2    Martin, J.A.3    De Ceaurriz, J.4
  • 33
    • 70349183432 scopus 로고    scopus 로고
    • A high-throughput test to detect C.E.R.A doping in blood
    • Lamon S, Giraud S, Egli L et al. A high-throughput test to detect C.E.R.A. doping in blood. J. Pharm. Biomed. Anal. 50(5), 954-958 (2009).
    • (2009) J. Pharm. Biomed. Anal. , vol.50 , Issue.5 , pp. 954-958
    • Lamon, S.1    Giraud, S.2    Egli, L.3
  • 34
    • 33748690610 scopus 로고    scopus 로고
    • Preclinical evaluation of Hematide™, a novel erythropoiesis stimulating agent, for the treatment of anemia
    • Fan Q, Leuther KK, Holmes CP et al. Preclinical evaluation of Hematide™, a novel erythropoiesis stimulating agent, for the treatment of anemia. Exp. Hematol. 34(10), 1303-1311 (2006).
    • (2006) Exp. Hematol. , vol.34 , Issue.10 , pp. 1303-1311
    • Fan, Q.1    Leuther, K.K.2    Holmes, C.P.3
  • 35
    • 80655131163 scopus 로고    scopus 로고
    • Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients
    • Macdougall IC, Wiecek A, Tucker B et al. Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 6(11), 2579-2586 (2011).
    • (2011) Clin. J. Am. Soc. Nephrol. , vol.6 , Issue.11 , pp. 2579-2586
    • Macdougall, I.C.1    Wiecek, A.2    Tucker, B.3
  • 36
    • 33748679131 scopus 로고    scopus 로고
    • Evaluation of the safety and pharmacodynamics of Hematide™, a novel erythropoietic agent, in a Phase I, double-blind, placebo-controlled, dose-escalation study in healthy volunteers
    • Stead RB, Lambert J, Wessels D et al. Evaluation of the safety and pharmacodynamics of Hematide™, a novel erythropoietic agent, in a Phase I, double-blind, placebo-controlled, dose-escalation study in healthy volunteers. Blood 108(6), 1830-1834 (2006).
    • (2006) Blood , vol.108 , Issue.6 , pp. 1830-1834
    • Stead, R.B.1    Lambert, J.2    Wessels, D.3
  • 37
    • 34447636387 scopus 로고    scopus 로고
    • Hematide™ is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model
    • Woodburn KW, Fan Q, Winslow S et al. Hematide™ is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model. Exp. Hematol. 35(8), 1201-1208 (2007).
    • (2007) Exp. Hematol. , vol.35 , Issue.8 , pp. 1201-1208
    • Woodburn, K.W.1    Fan, Q.2    Winslow, S.3
  • 38
    • 84862532659 scopus 로고    scopus 로고
    • Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events
    • Green JM, Leu K, Worth A et al. Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events. Exp. Hematol. 40(7), 575-587 (2012).
    • (2012) Exp. Hematol. , vol.40 , Issue.7 , pp. 575-587
    • Green, J.M.1    Leu, K.2    Worth, A.3
  • 39
    • 70350433566 scopus 로고    scopus 로고
    • Police find range of drugs after trawling bins used by Tour De France cyclists
    • Benkimoun P. Police find range of drugs after trawling bins used by Tour De France cyclists. BMJ 339, b4201 (2009).
    • (2009) BMJ , vol.339
    • Benkimoun, P.1
  • 40
    • 0036301408 scopus 로고    scopus 로고
    • Strategies for rhEPO detection in sport
    • Kazlauskas R, Howe C, Trout G. Strategies for rhEPO detection in sport. Clin. J. Sport Med. 12(4), 229-235 (2002).
    • (2002) Clin. J. Sport Med. , vol.12 , Issue.4 , pp. 229-235
    • Kazlauskas, R.1    Howe, C.2    Trout, G.3
  • 41
    • 80655124644 scopus 로고    scopus 로고
    • Methods for detection and confirmation of Hematide™/ peginesatide in anti-doping samples
    • Leuenberger N, Saugy J, Mortensen RB, Schatz PJ, Giraud S, Saugy M. Methods for detection and confirmation of Hematide™/ peginesatide in anti-doping samples. Forensic Sci. Int. 213(1-3), 15-19 (2011).
    • (2011) Forensic Sci. Int. , vol.213 , Issue.1-3 , pp. 15-19
    • Leuenberger, N.1    Saugy, J.2    Mortensen, R.B.3    Schatz, P.J.4    Giraud, S.5    Saugy, M.6
  • 42
    • 79959725994 scopus 로고    scopus 로고
    • Syn thesis, characterisation and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes
    • Möller I, Thomas A, Geyer H, Schänzer W, Thevis M. Synthesis, characterisation and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. Rapid Commun. Mass Spectrom. 25(15), 2115-2123 (2011).
    • (2011) Rapid Commun. Mass Spectrom. , vol.25 , Issue.15 , pp. 2115-2123
    • Möller, I.1    Thomas, A.2    Geyer, H.3    Schänzer, W.4    Thevis, M.5
  • 45
    • 34548229364 scopus 로고    scopus 로고
    • Fcrn: The neonatal Fc receptor comes of age
    • Roopenian DC, Akilesh S. FcRn: The neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7(9), 715-725 (2007).
    • (2007) Nat. Rev. Immunol. , vol.7 , Issue.9 , pp. 715-725
    • Roopenian, D.C.1    Akilesh, S.2
  • 46
    • 0037025895 scopus 로고    scopus 로고
    • Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung
    • Spiekermann GM, Finn PW, Ward ES et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung. J. Exp. Med. 196(3), 303-310 (2002).
    • (2002) J. Exp. Med. , vol.196 , Issue.3 , pp. 303-310
    • Spiekermann, G.M.1    Finn, P.W.2    Ward, E.S.3
  • 47
    • 33750699277 scopus 로고    scopus 로고
    • Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway
    • Bitonti AJ, Dumont JA. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Adv. Drug Deliv. Rev. 58(9-10), 1106-1118 (2006).
    • (2006) Adv. Drug Deliv. Rev. , vol.58 , Issue.9-10 , pp. 1106-1118
    • Bitonti, A.J.1    Dumont, J.A.2
  • 49
    • 84870246919 scopus 로고    scopus 로고
    • Detection of EPO-Fc fusion protein in human blood: Screening and confirmation protocols for sports drug testing
    • In press
    • Reichel C, Thevis M. Detection of EPO-Fc fusion protein in human blood: Screening and confirmation protocols for sports drug testing. Drug Test. Anal. (2012) (In press).
    • (2012) Drug Test. Anal.
    • Reichel, C.1    Thevis, M.2
  • 50
    • 0028816847 scopus 로고
    • Purification and characterization of hypoxia-inducible factor 1
    • Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270(3), 1230-1237 (1995).
    • (1995) J. Biol. Chem. , vol.270 , Issue.3 , pp. 1230-1237
    • Wang, G.L.1    Semenza, G.L.2
  • 51
    • 0030968939 scopus 로고    scopus 로고
    • Targeting gene expression to hypoxic tumor cells
    • Dachs GU, Patterson AV, Firth JD et al. Targeting gene expression to hypoxic tumor cells. Nat. Med. 3(5), 515-520 (1997).
    • (1997) Nat. Med. , vol.3 , Issue.5 , pp. 515-520
    • Dachs, G.U.1    Patterson, A.V.2    Firth, J.D.3
  • 52
    • 0026468180 scopus 로고
    • A nuclear factor induced by hypoxia via De novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
    • Semenza GL, Wang GL. A nuclear factor induced by hypoxia via De novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12(12), 5447-5454 (1992).
    • (1992) Mol. Cell. Biol. , vol.12 , Issue.12 , pp. 5447-5454
    • Semenza, G.L.1    Wang, G.L.2
  • 53
    • 0029761644 scopus 로고    scopus 로고
    • Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
    • Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16(9), 4604-4613 (1996).
    • (1996) Mol. Cell. Biol. , vol.16 , Issue.9 , pp. 4604-4613
    • Forsythe, J.A.1    Jiang, B.H.2    Iyer, N.V.3
  • 54
    • 77953854244 scopus 로고    scopus 로고
    • Hypoxic regulation of erythropoiesis and iron metabolism
    • Haase VH. Hypoxic regulation of erythropoiesis and iron metabolism. Am. J. Physiol. Renal Physiol. 299(1), F1-F13 (2010).
    • (2010) Am. J. Physiol. Renal Physiol. , vol.299 , Issue.1
    • Haase, V.H.1
  • 55
    • 70449527373 scopus 로고    scopus 로고
    • Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing
    • Webb JD, Coleman ML, Pugh CW. Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing. Cell Mol. Life Sci. 66(22), 3539-3554 (2009).
    • (2009) Cell Mol. Life Sci. , vol.66 , Issue.22 , pp. 3539-3554
    • Webb, J.D.1    Coleman, M.L.2    Pugh, C.W.3
  • 56
    • 0035917808 scopus 로고    scopus 로고
    • Targeting of HIF-alpha to the von Hippel- Lindau ubiquitylation complex by O2- regulated prolyl hydroxylation
    • Jaakkola P, Mole DR, Tian YM et al. Targeting of HIF-alpha to the von Hippel- Lindau ubiquitylation complex by O2- regulated prolyl hydroxylation. Science 292(5516), 468-472 (2001).
    • (2001) Science , vol.292 , Issue.5516 , pp. 468-472
    • Jaakkola, P.1    Mole, D.R.2    Tian, Y.M.3
  • 57
    • 34547493149 scopus 로고    scopus 로고
    • Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases
    • Bruegge K, Jelkmann W, Metzen E. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases. Curr. Med. Chem. 14(17), 1853-1862 (2007).
    • (2007) Curr. Med. Chem. , vol.14 , Issue.17 , pp. 1853-1862
    • Bruegge, K.1    Jelkmann, W.2    Metzen, E.3
  • 58
    • 84862783287 scopus 로고    scopus 로고
    • Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents
    • Tanaka T, Nangaku M. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents. Exp. Cell Res. 318(9), 1068-1073 (2012).
    • (2012) Exp. Cell Res. , vol.318 , Issue.9 , pp. 1068-1073
    • Tanaka, T.1    Nangaku, M.2
  • 59
    • 65649123829 scopus 로고    scopus 로고
    • Erythropoiesis stimulating agents and techniques: A challenge for doping analysts
    • Jelkmann W. Erythropoiesis stimulating agents and techniques: A challenge for doping analysts. Curr. Med. Chem. 16(10), 1236-1247 (2009).
    • (2009) Curr. Med. Chem. , vol.16 , Issue.10 , pp. 1236-1247
    • Jelkmann, W.1
  • 60
    • 75149138761 scopus 로고    scopus 로고
    • Prolyl hydroxylases and therapeutics
    • Smith TG, Talbot NP. Prolyl hydroxylases and therapeutics. Antioxid. Redox Signal. 12(4), 431-433 (2010).
    • (2010) Antioxid. Redox Signal. , vol.12 , Issue.4 , pp. 431-433
    • Smith, T.G.1    Talbot, N.P.2
  • 61
    • 78649876180 scopus 로고    scopus 로고
    • Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD
    • Bernhardt WM, Wiesener MS, Scigalla P et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J. Am. Soc. Nephrol. 21(12), 2151-2156 (2010).
    • (2010) J. Am. Soc. Nephrol. , vol.21 , Issue.12 , pp. 2151-2156
    • Bernhardt, W.M.1    Wiesener, M.S.2    Scigalla, P.3
  • 62
    • 84870248829 scopus 로고    scopus 로고
    • Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis
    • doi:10.1002/ dta.390 Epub ahead of print
    • Beuck S, Schanzer W, Thevis M. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. Drug Test. Anal. doi:10.1002/ dta.390 (2012) (Epub ahead of print).
    • (2012) Drug Test. Anal.
    • Beuck, S.1    Schanzer, W.2    Thevis, M.3
  • 63
    • 77955503450 scopus 로고    scopus 로고
    • Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis
    • Thevis M, Thomas A, Kohler M et al. Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis. Eur. J. Mass Spectrom. 16(3), 301-312 (2010).
    • (2010) Eur. J. Mass Spectrom. , vol.16 , Issue.3 , pp. 301-312
    • Thevis, M.1    Thomas, A.2    Kohler, M.3
  • 64
    • 84855248903 scopus 로고    scopus 로고
    • Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research
    • Beuck S, Bornatsch W, Lagojda A, Schänzer W, Thevis M. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. Drug Test. Anal. 3(11-12), 756-770 (2011).
    • (2011) Drug Test. Anal. , vol.3 , Issue.11-12 , pp. 756-770
    • Beuck, S.1    Bornatsch, W.2    Lagojda, A.3    Schänzer, W.4    Thevis, M.5
  • 66
    • 80052423299 scopus 로고    scopus 로고
    • Blood doping and its detection
    • Jelkmann W, Lundby C. Blood doping and its detection. Blood 118(9), 2395-2404 (2011).
    • (2011) Blood , vol.118 , Issue.9 , pp. 2395-2404
    • Jelkmann, W.1    Lundby, C.2
  • 67
    • 0036785428 scopus 로고    scopus 로고
    • Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy
    • Binley K, Askham Z, Iqball S et al. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood 100(7), 2406-2413 (2002).
    • (2002) Blood , vol.100 , Issue.7 , pp. 2406-2413
    • Binley, K.1    Askham, Z.2    Iqball, S.3
  • 69
    • 0035894739 scopus 로고    scopus 로고
    • Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: The retina as a model
    • Auricchio A, Kobinger G, Anand V et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: The retina as a model. Hum. Mol. Genet. 10(26), 3075-3081 (2001).
    • (2001) Hum. Mol. Genet. , vol.10 , Issue.26 , pp. 3075-3081
    • Auricchio, A.1    Kobinger, G.2    Anand, V.3
  • 70
    • 10744229842 scopus 로고    scopus 로고
    • Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog and nonhuman primate after subretinal delivery
    • Weber M, Rabinowitz J, Provost N et al. Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog and nonhuman primate after subretinal delivery. Mol. Ther. 7(6), 774-781 (2003).
    • (2003) Mol. Ther. , vol.7 , Issue.6 , pp. 774-781
    • Weber, M.1    Rabinowitz, J.2    Provost, N.3
  • 71
    • 33645840126 scopus 로고    scopus 로고
    • Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors
    • Stieger K, Le Meur G, Lasne F et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol. Ther. 13(5), 967-975 (2006).
    • (2006) Mol. Ther. , vol.13 , Issue.5 , pp. 967-975
    • Stieger, K.1    Le Meur, G.2    Lasne, F.3
  • 72
    • 70349849524 scopus 로고    scopus 로고
    • Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates
    • Menzel O, Birraux J, Wildhaber BE et al. Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. Mol. Ther. 17(10), 1754-1760 (2009).
    • (2009) Mol. Ther. , vol.17 , Issue.10 , pp. 1754-1760
    • Menzel, O.1    Birraux, J.2    Wildhaber, B.E.3
  • 73
    • 22644444463 scopus 로고    scopus 로고
    • Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins
    • Brill-Almon E, Stern B, Afik D et al. Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Mol. Ther. 12(2), 274-282 (2005).
    • (2005) Mol. Ther. , vol.12 , Issue.2 , pp. 274-282
    • Brill-Almon, E.1    Stern, B.2    Afik, D.3
  • 75
    • 77955664126 scopus 로고    scopus 로고
    • Gene doping detection: Evaluation of approach for direct detection of gene transfer using erythropoietin as a model system
    • Baoutina A, Coldham T, Bains GS, Emslie KR. Gene doping detection: Evaluation of approach for direct detection of gene transfer using erythropoietin as a model system. Gene Ther. 17(8), 1022-1032 (2010).
    • (2010) Gene Ther. , vol.17 , Issue.8 , pp. 1022-1032
    • Baoutina, A.1    Coldham, T.2    Bains, G.S.3    Emslie, K.R.4
  • 76
    • 79952484973 scopus 로고    scopus 로고
    • Direct and long-term detection of gene doping in conventional blood samples
    • Beiter T, Zimmermann M, Fragasso A et al. Direct and long-term detection of gene doping in conventional blood samples. Gene Ther. 18(3), 225-231 (2011).
    • (2011) Gene Ther. , vol.18 , Issue.3 , pp. 225-231
    • Beiter, T.1    Zimmermann, M.2    Fragasso, A.3
  • 77
    • 79960113180 scopus 로고    scopus 로고
    • Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: Implications for gene doping
    • Ni W, Le Guiner C, Gernoux G, Penaud- Budloo M, Moullier P, Snyder RO. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: Implications for gene doping. Gene Ther. 18(7), 709-718 (2011).
    • (2011) Gene Ther. , vol.18 , Issue.7 , pp. 709-718
    • Ni, W.1    Le Guiner, C.2    Gernoux, G.3    Penaud- Budloo, M.4    Moullier, P.5    Snyder, R.O.6
  • 78
    • 84870254053 scopus 로고    scopus 로고
    • Detection of EPO doping and blood doping: The haematological module of the Athlete Biological Passport
    • doi:10.1002/dta.406 Epub ahead of print
    • Schumacher YO, Saugy M, Pottgiesser T, Robinson N. Detection of EPO doping and blood doping: The haematological module of the Athlete Biological Passport. Drug Test. Anal. doi:10.1002/dta.406 (2012) (Epub ahead of print).
    • (2012) Drug Test. Anal.
    • Schumacher, Y.O.1    Saugy, M.2    Pottgiesser, T.3    Robinson, N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.